Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled time : 12:15 save search
Spero Therapeutics Submits New Drug Application to U.S. FDA for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis
Published: 2021-10-28 (Crawled : 12:15) - globenewswire.com
SPRO | $1.435 2.14% 2.09% 120K
|
Health Technology
|
| O: 0.18%
H: 7.08%
C: 7.08%
new drug treatment fda application drug injection infections
Aptevo Therapeutics Presents Promising Clinical Data on Its Lead Leukemia Drug Candidate APVO436 at The Second Virtual Conference on Controversies in Leukemias, Euroleuk2021
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
APVO | $0.7475 5.28% 5.02% 350K
|
Health Technology
|
| O: -0.96%
H: 2.83%
C: 0.69%
drug leukemia conference apvo436
Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results
Published: 2021-10-12 (Crawled : 12:15) - biospace.com/
WINT | $5.52 1.28% 1.27% 81K
|
Health Technology
|
| O: 1.3%
H: 1.28%
C: -2.56%
treatment eye cardiologists results drug research cardio
CNS Pharmaceuticals Doses First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2021-09-30 (Crawled : 12:15) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.64%
H: 1.89%
C: -5.08%
CNSP | News | $0.201 0.95% 0.95% 120K
|
Health Technology
|
| O: -3.75%
H: 3.9%
C: -3.25%
berubicin treatment fda potential fast track drug designation glioblastoma
Marinus Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
MRNS | $1.455 -1.36% -1.37% 2.9M
|
Health Technology
|
| O: 3.32%
H: 4.57%
C: -0.59%
new drug fda fda acceptance drug application
Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE®
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
RYTM A | $39.945 2.4% 2.34% 410K
|
Health Technology
|
| O: 2.11%
H: 1.03%
C: -3.44%
new drug food drug submission imcivree application
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
Published: 2021-09-15 (Crawled : 12:15) - globenewswire.com
RVMD | $36.25 -0.49% -0.5% 1.4M
|
Health Technology
|
| O: -0.34%
H: 4.55%
C: 3.97%
drug
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development SummitCompany’s Scientific Leadership to Highlight Key Findings from Ongoing RAS(ON) Inhibitor Programs
Published: 2021-09-15 (Crawled : 12:15) - biospace.com/
RVMD | $36.25 -0.49% -0.5% 1.4M
|
Health Technology
|
| O: -0.34%
H: 4.55%
C: 3.97%
ongoing drug
With Market Size Valued at $2.6 Billion by 2026, it`s a Healthy Outlook for the Global Artificial Intelligence (AI) in Drug Discovery Market
Published: 2021-08-26 (Crawled : 12:15) - prnewswire.com
NVDA | News | $823.87 3.61% 4.25% 43M
|
Electronic Technology
|
| O: -0.06%
H: 0.63%
C: -0.59%
MSFT | News 4 | $407.24 1.57% 1.54% 15M
|
Technology Services
|
| O: -0.34%
H: 0.48%
C: -0.63%
GOOGL | News S | $158.17 1.21% 1.19% 21M
|
Technology Services
|
| O: -0.23%
H: 0.47%
C: -0.22%
GOOG | News 4 | $159.82 1.18% 1.17% 16M
|
Technology Services
|
| O: -0.23%
H: 0.36%
C: -0.35%
artificial intelligence drug discovery drug
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
Published: 2021-08-06 (Crawled : 12:15) - biospace.com/
TWST | $31.505 6.98% 6.51% 1.1M
|
Health Technology
|
| O: -0.36%
H: 0.96%
C: -10.43%
drug discovery drug bioscience
Arcutis Advances Science of Psoriasis Drug Development with New Precision Method for Measuring Mild-to-Moderate Psoriasis
Published: 2021-07-21 (Crawled : 12:15) - globenewswire.com
ARQT | $8.735 -2.29% -2.35% 1.6M
|
Health Technology
|
| O: 0.3%
H: 0.39%
C: -1.43%
drug psoriasis
Albireo Receives European Marketing Authorization of Bylvay™ (odevixibat), the First Drug Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC)
Published: 2021-07-19 (Crawled : 12:15) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 6.41%
H: 1.63%
C: -1.96%
treatment europe drug authorized
Entasis Therapeutics Introduces ETX0462, a First-in-Class Candidate, Targeting Multidrug-Resistant Gram-Negative and Biothreat Pathogens
Published: 2021-07-01 (Crawled : 12:15) - globenewswire.com
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: 0.75%
H: 4.46%
C: 4.46%
drug iot pathogens
TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma
Published: 2021-06-29 (Crawled : 12:15) - globenewswire.com
TCON | $1.875 3.02% 2.93% 55K
|
Health Technology
|
| O: 3.03%
H: 1.1%
C: -4.62%
drug designation soft tissue
Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer
Published: 2021-06-24 (Crawled : 12:15) - biospace.com/
PIRS | $12.0 2.67% 2.6% 120K
|
Health Technology
|
| O: 5.65%
H: 22.19%
C: 16.84%
treatment cancer drug designation
VectivBio Receives FDA Orphan Drug Designation for Apraglutide for Acute Graft-Versus-Host DiseasePhase 2 trial expected to begin in the first quarter of 2022
Published: 2021-06-24 (Crawled : 12:15) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: 8.7%
H: 1.36%
C: -6.48%
disease fda phase 2 drug trial designation
BOQI International Medical Inc. Announces That Its Wholesale Drug Distribution Subsidiary, Shude Pharmaceutical, Was Awarded A RMB 20 Million Contract
Published: 2021-06-02 (Crawled : 12:15) - globenewswire.com
BIMI | $1.32 17.86% 15.15% 86K
|
Retail Trade
|
| O: 5.3%
H: 2.88%
C: -2.16%
contract distribution drug
Can-Fite To Initiate Phase IIb NASH Study with its Drug Candidate Namodenoson
Published: 2021-06-02 (Crawled : 12:15) - biospace.com/
CANF | $1.97 -0.51% 0.0% 3.8K
|
Health Technology
|
| O: -0.94%
H: 2.37%
C: 0.0%
drug nash namodenoson
Nkarta Receives NKX019 IND Clearance from U.S. Food and Drug Administration for Treatment of Relapsed/Refractory B Cell Malignancies
Published: 2021-04-28 (Crawled : 12:15) - globenewswire.com
NKTX | $7.55 2.17% 2.12% 710K
|
Health Technology
|
| O: 0.27%
H: 1.03%
C: -0.85%
food treatment drug clearance t-cell
Stealth BioTherapeutics CEO to Give Keynote Presentation at Mitochondria-Targeted Drug Development Summit
Published: 2021-04-26 (Crawled : 12:15) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 0.0%
H: 3.33%
C: 0.0%
presentation drug ceo iot leo
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.